← Back to Search
Can Early Palliative Care With Anticancer Treatment Improve Overall Survival And Patient-related Outcomes In Advanced Lung Cancer Patients? A Review Of The Literature
M. Ambroggi, C. Biasini, Ilaria Toscani, E. Orlandi, R. Bertè, Martina Mazzari, L. Cavanna
Published 2018 · Medicine
Download PDFAnalyze on Scholarcy
PurposeMetastatic non-small-cell lung cancer (NSCLC), the leading cause of death from cancer worldwide, is a debilitating disease that results in a high burden of symptoms and poor quality of life; the estimated prognosis after the diagnosis has been established was less than 1 year until some years ago. At the present, the new targeted therapies and immunotherapy are changing the course of the disease. However, advanced NSCLC remains an incurable disease, with a poor prognosis for the majority of the affected patients, so that quality of life and relief from symptoms are primary objectives of treatment. Some evidences suggest that early palliative care (EPC) for these patients can improve quality of life and even survival.DesignA systematic review of the studies evaluating the impact on objective and on patient-reported outcomes of the introduction of EPC in opposition to standard care (SC), for advanced lung cancer patients, was performed. Because of the small number of studies conducted in this area, retrospective studies were also considered for the review.ResultsFive studies were included because they matched the inclusion criteria previously defined as relevant for the study. The review found that both survival and quality of life were better for patients included in EPC groups.ConclusionsWhile results of the studies included in this review are not always comparable because different methods and scales have been used, there is enough evidence for clinical oncologists to implement the use of EPC in clinical practice for advanced lung cancer patients.
This paper references
Support Care Cancer
AA Wright (2008)
Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer: a prospective study using the Lung Cancer Symptom Scale in a community hospital.
S. Lutz (2001)
Associations between end-of-life discussions, patient Support Care Cancer mental health, medical care near death, and caregiver bereavement adjustment
AA Wright (2008)
The role of investigational therapy in management of patients with advanced metastatic malignancy.
E. Freireich (2009)
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.
R. Rosell (2012)
PROFILE 1014 investigators . First - line crizotinib versus chemotherapy in ALK - positive lung cancer
J Mazieres (2015)
Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center
D. Hui (2010)
Position Paper of the Italian Association of Medical Oncology on Early Palliative Care in Oncology Practice (Simultaneous Care)
V. Zagonel (2017)
Impact of early palliative interventions on the outcomes of care for patients with non-small cell lung cancer
C. Nieder (2016)
Early palliative care for patients with metastatic non-small-cell lung cancer.
J. Temel (2010)
METas a possible target for non-smallcell lung cancer
AA Sadiq (2013)
Late referrals to palliative care units in Japan: nationwide follow-up survey and effects of palliative care team involvement after the Cancer Control Act.
T. Morita (2009)
Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data.
Penny Hopwood (2000)
The project ENABLE II randomized controlled trial to improve palliative care for rural patients with advanced cancer: baseline findings, methodological challenges, and solutions.
Marie Bakitas (2009)
Distance as a Barrier to Cancer Diagnosis and Treatment: Review of the Literature.
M. Ambroggi (2015)
Effects of early palliative care in patients with lung and GI cancer: a randomized clinical trial
JS Temel (2017)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
J. Brahmer (2015)
Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party.
P. Hopwood (1995)
The problem of caring for the dying in a general hospital; the palliative care unit as a possible solution.
B. Mount (1976)
Early palliative care for patients with advanced cancer: a clusterrandomised controlled trial
C Zimmermann (2014)
patients : a retrospective cohort study
N Fadul (2009)
Availability and Integration of Palliative Care at US Cancer Centers (DRAFT)
Pedro E Perez-Cruz (2018)
Interval between palliative care referral and death among patients treated at a comprehensive cancer center.
W. Cheng (2005)
Integrating supportive and palliative care in the trajectory of cancer: establishing goals and models of care.
E. Bruera (2010)
Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients.
J. Temel (2007)
Discharge outcomes and survival of patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center.
D. Hui (2010)
PROFILE 1014 Investigators (2014) PROFILE 1014 investigators. First-line crizotinib versus chemotherapy in ALK-positive lung cancer
BJ Solomon (2014)
Late referrals to specialized palliative care service in Japan.
T. Morita (2005)
The assessment and management of family distress during palliative care
T. Zaider (2009)
Palliative care models: international perspective.
E. Bruera (2002)
Integrated Onco-Palliative Care Associated With Prolonged Survival Compared to Standard Care for Patients With Advanced Lung Cancer: A Retrospective Review.
J. King (2016)
Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center.
F. Braiteh (2007)
Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers?
I. Higginson (2003)
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
T. Mok (2009)
Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment.
A. Wright (2008)
Supportive versus palliative care: What's in a name?
N. Fadul (2009)
Do hospital-based palliative teams improve care for patients or families at the end of life?
I. Higginson (2002)
World Health Organization: National Cancer Control Programmes: policies and managerial guidelines
Impact of a half-day multidisciplinary symptom control and palliative care outpatient clinic in a comprehensive cancer center on recommendations, symptom intensity, and patient satisfaction: a retrospective descriptive study.
F. Strasser (2004)
Availability and integration of palliative care at US cancer centers.
D. Hui (2010)
Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.
J. Mazieres (2015)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
R. Herbst (2016)
A Jemal (2009)
2015)Nivolumab versus docetaxel in advanced nonsquamous nonsmall-cell lung Cancer
H Borghaei (2015)
Timing of palliative care referral and symptom burden in phase I cancer patients: A retrospective cohort study.
H. Parsons (2010)
Interval between first palliative care consult and death in patients diagnosed with advanced cancer at a comprehensive cancer center.
B. Osta (2008)
Disparity in cancer survival between urban and rural patients--how can clinicians help reduce it?
S. Sabesan (2009)
Symptom control in palliative care--Part I: oncology as a paradigmatic example.
S. Dalal (2006)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
H. Borghaei (2015)
N. Dubrawsky (1989)
admit - ted to an acute palliative care unit at a comprehensive cancer center : a simultaneous care model
D Hui (2010)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
A. Liberati (2009)
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
A. Shaw (2013)
This paper is referenced by
Comparison of Life-Sustaining Treatment in Terminal Cancer Patients between a Cancer and Hospice Unit after Do-Not-Resuscitate Orders
E. J. Nam (2018)
A. Matsuda (2020)
Electronic symptom monitoring in patients with metastatic lung cancer: a feasibility study
R. B. Friis (2020)
Does early palliative identification improve the use of palliative care services?
N. Mittmann (2020)
Multidisciplinary team care in advanced lung cancer.
A. Kowalczyk (2020)
Feasibility and Utility of Incorporating Patient-Reported Outcomes into Surveillance Strategies for Advanced Lung Cancer
L. Cavanna (2020)
Primary Care Revisited: Interdisciplinary Perspectives for a New Era
Yuk Fai Fong (2020)
Quantification of quality of life improvement after appropriate symptoms control in cancer patients with breakthrough pain: A four-week follow-up study in a palliative care unit
Miguel Ángel Núñez Viejo (2019)
Palliative care in the context of immune and targeted therapies: A qualitative study of bereaved carers’ experiences in metastatic melanoma
J. Fox (2020)
Evaluation of a communication skills training to facilitate addressing palliative care related topics in advanced cancer patients: study protocol of a multicenter randomized controlled trial (PALLI-KOM)
N. Harnischfeger (2020)
Prognostic value of site-specific metastases in lung cancer: A population based study
J. Li (2019)
How Effective Is Palliative Care in Improving Patient Outcomes?
Sarah Milazzo (2020)
Integrating early palliative care into routine practice for patients with cancer: A mixed methods evaluation of the INTEGRATE Project
Jenna M Evans (2019)
Illness Perceptions and Quality of Life in Patients with Non-Small-Cell Lung Cancer: A 3-Month Follow-Up Pilot Study
M. Vollmann (2020)
Knowledge and attitudes toward end-of-life care among community health care providers and its influencing factors in China
Hongrui Shi (2019)